{"id":"https://openalex.org/W2000816161","doi":"https://doi.org/10.1097/00004850-199903000-00007","title":"The treatment of negative symptoms: a clinical and methodological study","display_name":"The treatment of negative symptoms: a clinical and methodological study","publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W2000816161","doi":"https://doi.org/10.1097/00004850-199903000-00007","mag":"2000816161","pmid":"https://pubmed.ncbi.nlm.nih.gov/10220125"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-199903000-00007","doi":"https://doi.org/10.1097/00004850-199903000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199903000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008252939","display_name":"Y.D. Lapierre","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800991225","display_name":"Royal Ottawa Mental Health Centre","ror":"https://ror.org/056vnsb08","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800991225"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Y D Lapierre","raw_affiliation_strings":["Department of Psychiatry, Royal Ottawa Hospital, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Royal Ottawa Hospital, Ontario, Canada","institution_ids":["https://openalex.org/I2800991225"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086865751","display_name":"Carmella Angus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149652","display_name":"AstraZeneca (Canada)","ror":"https://ror.org/04n8fbz89","country_code":"CA","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210149652"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"C Angus","raw_affiliation_strings":["the Medical Department, Astra Pharma Inc., Mississauga, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Medical Department, Astra Pharma Inc., Mississauga, Ontario","institution_ids":["https://openalex.org/I4210149652"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086031332","display_name":"A. George Awad","orcid":"https://orcid.org/0000-0002-9219-2083","observed_orcids":["https://orcid.org/0000-0002-9219-2083"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A G Awad","raw_affiliation_strings":["the Department of Psychiatry, Clarke Institute of Psychiatry, Toronto, Ontario","From the Department of Psychiatry, Clarke Institute of Psychiatry, Toronto, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Clarke Institute of Psychiatry, Toronto, Ontario","institution_ids":[]},{"raw_affiliation_string":"From the Department of Psychiatry, Clarke Institute of Psychiatry, Toronto, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109765988","display_name":"B. Saxena","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163739","display_name":"Hamilton Psychiatric Hospital","ror":"https://ror.org/01h8zk368","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210163739","https://openalex.org/I59293822"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"B M Saxena","raw_affiliation_strings":["the Department of Psychiatry, Hamilton Psychiatric Hospital, Hamilton, Ontario","From the Department of Psychiatry, Hamilton Psychiatric Hospital, Hamilton, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Hamilton Psychiatric Hospital, Hamilton, Ontario","institution_ids":["https://openalex.org/I4210163739"]},{"raw_affiliation_string":"From the Department of Psychiatry, Hamilton Psychiatric Hospital, Hamilton, Ontario","institution_ids":["https://openalex.org/I4210163739"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108601673","display_name":"B. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800991225","display_name":"Royal Ottawa Mental Health Centre","ror":"https://ror.org/056vnsb08","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800991225"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"B Jones","raw_affiliation_strings":["the Department of Psychiatry, Royal Ottawa Hospital, Ottawa, Ontario","From the Department of Psychiatry, Royal Ottawa Hospital, Ottawa, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Royal Ottawa Hospital, Ottawa, Ontario","institution_ids":["https://openalex.org/I2800991225"]},{"raw_affiliation_string":"From the Department of Psychiatry, Royal Ottawa Hospital, Ottawa, Ontario","institution_ids":["https://openalex.org/I2800991225"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049858309","display_name":"Peter Williamson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Williamson","raw_affiliation_strings":["the Department of Psychiatry, London Psychiatric Hospital, London, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, London Psychiatric Hospital, London, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"P Vincent","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133239","display_name":"H\u00f4pital de l'Enfant-J\u00e9sus","ror":"https://ror.org/02p1gpn45","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210133239","https://openalex.org/I4210139015","https://openalex.org/I4405257837","https://openalex.org/I4405279980"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"P Vincent","raw_affiliation_strings":["the Department of Psychiatry, Hopital de I'Enfant Jesus, Quebec, Ontario","From the Department of Psychiatry, Hopital de I'Enfant Jesus, Quebec, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Hopital de I'Enfant Jesus, Quebec, Ontario","institution_ids":["https://openalex.org/I4210133239"]},{"raw_affiliation_string":"From the Department of Psychiatry, Hopital de I'Enfant Jesus, Quebec, Ontario","institution_ids":["https://openalex.org/I4210133239"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038830031","display_name":"R Carle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R Carle","raw_affiliation_strings":["the Department of Psychiatry, Centre Hospitaller Hotel-Dieu de Sherbrooke, Sherbrooke, Quebec"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Centre Hospitaller Hotel-Dieu de Sherbrooke, Sherbrooke, Quebec","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111573130","display_name":"Y.J. Lavall\u00e9e","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Y J Lavallee","raw_affiliation_strings":["the Department of Psychiatry, CHU de Sherbrooke, Sherbrooke, Quebec","From the Department of Psychiatry, CHU de Sherbrooke, Sherbrooke, Quebec"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, CHU de Sherbrooke, Sherbrooke, Quebec","institution_ids":[]},{"raw_affiliation_string":"From the Department of Psychiatry, CHU de Sherbrooke, Sherbrooke, Quebec","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090475015","display_name":"Rahul Manchanda","orcid":"https://orcid.org/0000-0002-6367-3005","observed_orcids":["https://orcid.org/0000-0002-6367-3005"]},"institutions":[{"id":"https://openalex.org/I4210094837","display_name":"University Hospital","ror":"https://ror.org/00r664k32","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800925808","https://openalex.org/I4210094837"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"R Manchanda","raw_affiliation_strings":["the Department of Psychiatry, University Hospital, London, Ontario","From the Department of Psychiatry, University Hospital, London, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, University Hospital, London, Ontario","institution_ids":["https://openalex.org/I4210094837"]},{"raw_affiliation_string":"From the Department of Psychiatry, University Hospital, London, Ontario","institution_ids":["https://openalex.org/I4210094837"]}]},{"author_position":"middle","author":{"id":null,"display_name":"B Gauthier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141135","display_name":"H\u00f4pital du Sacr\u00e9-C\u0153ur de Montr\u00e9al","ror":"https://ror.org/03ey0g045","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210141135"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"B Gauthier","raw_affiliation_strings":["the Department of Psychiatry, Hopital du Sacre-Coeur, Montreal, Quebec","From the Department of Psychiatry, Hopital du Sacre-Coeur, Montreal, Quebec"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Hopital du Sacre-Coeur, Montreal, Quebec","institution_ids":["https://openalex.org/I4210141135"]},{"raw_affiliation_string":"From the Department of Psychiatry, Hopital du Sacre-Coeur, Montreal, Quebec","institution_ids":["https://openalex.org/I4210141135"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089059556","display_name":"Marc-Alain Wolf","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799434747","display_name":"Douglas Mental Health University Institute","ror":"https://ror.org/05dk2r620","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2799434747"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"M A Wolf","raw_affiliation_strings":["the Department of Psychiatry, Douglas Hospital, Verdun, Quebec","From the Department of Psychiatry, Douglas Hospital, Verdun, Quebec"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Douglas Hospital, Verdun, Quebec","institution_ids":["https://openalex.org/I2799434747"]},{"raw_affiliation_string":"From the Department of Psychiatry, Douglas Hospital, Verdun, Quebec","institution_ids":["https://openalex.org/I2799434747"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046761671","display_name":"Michael D. Teehan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M D Teehan","raw_affiliation_strings":["the Department of Psychiatry, CampHill Medical Centre, Halifax, Nova Scotia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, CampHill Medical Centre, Halifax, Nova Scotia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109331766","display_name":"J.F. Denis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405287159","display_name":"H\u00f4pital de la Cit\u00e9-de-la-Sant\u00e9","ror":"https://ror.org/049h0x810","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405287159"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"J F Denis","raw_affiliation_strings":["the Department of Psychiatry, Cite De la Sante de Laval, Laval, Quebec, Canada","From the Department of Psychiatry, Cite De la Sante de Laval, Laval, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Cite De la Sante de Laval, Laval, Quebec, Canada","institution_ids":["https://openalex.org/I4405287159"]},{"raw_affiliation_string":"From the Department of Psychiatry, Cite De la Sante de Laval, Laval, Quebec, Canada","institution_ids":["https://openalex.org/I4405287159"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045972911","display_name":"ASHOK K. MALLA","orcid":"https://orcid.org/0000-0002-5863-4191","observed_orcids":["https://orcid.org/0000-0002-5863-4191"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"A K Malla","raw_affiliation_strings":["the Medical Department, Astra Arcus, Sodertalje, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Medical Department, Astra Arcus, Sodertalje, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110144719","display_name":"Lamidi Kola Oyewumi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L K Oyewumi","raw_affiliation_strings":["the Department of Psychiatry, London Psychiatric Hospital, London, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, London Psychiatric Hospital, London, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"E Busse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163739","display_name":"Hamilton Psychiatric Hospital","ror":"https://ror.org/01h8zk368","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210163739","https://openalex.org/I59293822"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"E Busse","raw_affiliation_strings":["the Department of Psychiatry, Hamilton Psychiatric Hospital, Hamilton, Ontario","From the Department of Psychiatry, Hamilton Psychiatric Hospital, Hamilton, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Hamilton Psychiatric Hospital, Hamilton, Ontario","institution_ids":["https://openalex.org/I4210163739"]},{"raw_affiliation_string":"From the Department of Psychiatry, Hamilton Psychiatric Hospital, Hamilton, Ontario","institution_ids":["https://openalex.org/I4210163739"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069276916","display_name":"Alain Labelle","orcid":"https://orcid.org/0000-0003-3414-3715","observed_orcids":["https://orcid.org/0000-0003-3414-3715"]},"institutions":[{"id":"https://openalex.org/I2800991225","display_name":"Royal Ottawa Mental Health Centre","ror":"https://ror.org/056vnsb08","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2800991225"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"A Labelle","raw_affiliation_strings":["the Department of Psychiatry, Royal Ottawa Hospital, Ottawa, Ontario","From the Department of Psychiatry, Royal Ottawa Hospital, Ottawa, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Department of Psychiatry, Royal Ottawa Hospital, Ottawa, Ontario","institution_ids":["https://openalex.org/I2800991225"]},{"raw_affiliation_string":"From the Department of Psychiatry, Royal Ottawa Hospital, Ottawa, Ontario","institution_ids":["https://openalex.org/I2800991225"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L Claesson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"L Claesson","raw_affiliation_strings":["the Medical Department, Astra Arcus, Sodertalje, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Medical Department, Astra Arcus, Sodertalje, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061637320","display_name":"Kerstin Grafford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"K Grafford","raw_affiliation_strings":["the Medical Department, Astra Arcus, Sodertalje, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Medical Department, Astra Arcus, Sodertalje, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6297,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.67535614,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":95},"biblio":{"volume":"14","issue":"2","first_page":"101","last_page":"112"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/negative-symptoms","display_name":"negative symptoms","score":0.7239999771118164},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9309999942779541},{"id":"https://openalex.org/keywords/remoxipride","display_name":"remoxipride","score":0.996999979019165},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9879999756813049},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.7319999933242798},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6119999885559082},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.6800000071525574},{"id":"https://openalex.org/keywords/social-functioning","display_name":"social functioning","score":0.7839999794960022}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8886384963989258},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.832950234413147},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.6108903884887695},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5855140686035156},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5803680419921875},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4928028881549835},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.48867347836494446},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4859572649002075},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4688749313354492},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4679485857486725},{"id":"https://openalex.org/C3019023267","wikidata":"https://www.wikidata.org/wiki/Q1441305","display_name":"Negative symptom","level":3,"score":0.4671193063259125},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4229605495929718},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.35386985540390015},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012565","descriptor_name":"Schizophrenic Psychology","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017330","descriptor_name":"Remoxipride","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017330","descriptor_name":"Remoxipride","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004850-199903000-00007","doi":"https://doi.org/10.1097/00004850-199903000-00007","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-199903000-00007","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:10220125","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10220125","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2558113028","https://openalex.org/W2234813253","https://openalex.org/W215201129","https://openalex.org/W2352043134","https://openalex.org/W1968568490","https://openalex.org/W2161796565","https://openalex.org/W1964232035","https://openalex.org/W2062932782","https://openalex.org/W2089998597","https://openalex.org/W2372529584"],"abstract_inverted_index":{"The":[0,25,126],"primary":[1,162],"objective":[2],"of":[3,14,86,120,138,149,161],"this":[4,50],"study":[5,26,51,151,160],"was":[6,77],"to":[7,42,92,118,158],"evaluate":[8],"the":[9,57,64,83,112,136,147,150,159],"efficacy,":[10],"safety":[11],"and":[12,37,63,66,99,123,133],"tolerability":[13],"remoxipride":[15,44,97,132],"(controlled":[16],"release)":[17],"versus":[18],"haloperidol":[19,101,134],"in":[20,82,165],"patients":[21,39],"with":[22,116,142],"negative":[23,74,121,139,163],"symptoms.":[24,75],"comprised":[27],"a":[28,78,153],"multicentre,":[29],"randomised,":[30],"double-blind,":[31],"parallel-group":[32],"clinical":[33],"trial.":[34],"Two":[35],"hundred":[36],"five":[38],"were":[40,52,106],"randomised":[41],"either":[43],"or":[45],"haloperidol.":[46],"Patients":[47],"eligible":[48],"for":[49,60,72,95],"aged":[53],"18-65":[54],"years,":[55],"met":[56],"DSM-III-R":[58],"diagnosis":[59],"chronic":[61],"schizophrenia":[62],"Positive":[65],"Negative":[67],"Symptoms":[68],"Scale":[69],"(PANSS)":[70],"criteria":[71],"predominant":[73],"There":[76,105],"statistically":[79],"significant":[80],"reduction":[81],"PANSS":[84,127],"scores":[85],"at":[87],"least":[88],"20%":[89],"from":[90],"baseline":[91],"last":[93],"rating":[94],"39":[96],"(49.4%)":[98],"45":[100],"(47.6%)":[102],"treated":[103],"patients.":[104],"no":[107],"statistical":[108],"differences":[109],"found":[110],"between":[111],"two":[113],"treatment":[114],"groups":[115],"respect":[117],"improvement":[119],"symptoms":[122,140,164],"adverse":[124],"events.":[125],"data":[128],"suggest":[129],"that":[130,155],"both":[131],"improve":[135],"cluster":[137],"concerned":[141],"social":[143],"functioning.":[144],"In":[145],"addition,":[146],"design":[148],"provides":[152],"methodology":[154],"is":[156],"appropriate":[157],"schizophrenia.":[166]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}